SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: wvalx who wrote (20539)4/15/1999 5:42:00 PM
From: VLAD  Read Replies (2) of 23519
 
wvalx:

Here is a copy of my e-mail sent to the Fools at the Fool:

OK Paul,

Let's see what you have to write up on Vivus INC.  Well over 400 Viagra
linked deaths in the USA alone and no press.  Why?  Astra/Zeneca to launch
MUSE in May.  International sales of Viagra stink as reported by Pfizer
today with only $44M in Q1 1999 international sales.  The Europeans aren't
pill popping maniacs.  They CARE about the safety profile of drugs and their
media isn't filled with hype as in the USA.

Come on Paul...how about some "EQUAL" time for us Vivus longs!!!

And Fat Herb:

Hey jerk!  Are you now going to give Vivus some fair and equal reporting?

Pfizer only had $44M in international sales on Viagra in Q1 1999 with 62
countries launched.  Domestic stats show over 430 Viagra linked deaths
reported to the FDA in the United States alone.  How about some press on
that or are you guys just concerned about your Pfizer portfolio?

Astra/Zeneca to launch MUSE in Europe next month.  MUSE sales have done fine
head to head against Viagra in England.  With good marketing MUSE will sell
relatively well because it works and it is safe.  That's right IT DOESN'T
KILL PEOPLE!!

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext